4-FLUORO-1H-INDOLE-5-CARBOXYLIC ACID, 95.0%, 250mg

Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)benzoate, 96%, 250mg

5-Bromothieno[2,3-b]pyridine, 95.0%, 5g

2-(1-(4-Fluorophenyl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 100mg

(4-Chloro-3,5-dimethyl-phenoxy)-acetic acid, 95.0%, 100mg

tert-Butyl (2R,4S)-2-(hydroxymethyl)-4-(trifluoromethyl)pyrrolidine-1-carboxylate, 98%, 100mg

4-(3-pyrrolidinyl)-1H-imidazole dihydrochloride, 95.0%, 250mg

tert-Butyl (3,3-difluoro-1-(hydroxymethyl)cyclobutyl)carbamate, 95.0%, 500mg

4-(3,4-Dichlorophenoxy)aniline, 98%, 250mg

(R)-1-Phenyl-3-(pyrrolidin-3-yl)urea, 1g

1-Bromo-4-dodecylbenzene>90.0%(GC)5g

4,6-Dibromopyrazolo[1,5-a]pyridine-3-carbonitrile, 96%, 1g

Afnio ICP soluzione standard, ROTI®Star, 10000 mg/l Hf, densità (D) ~1 g/cm³